Mass Transfer is a unique way of drying biologics. It operates at near room temperature – enabling the formulation of delicate biomolecules as particle-engineered powders that are thermostable and also highly suited for novel administration routes.
How can it expand the possibilities for your API?
What is Mass Transfer drying?
LaminarPace's Mass Transfer technique eliminates heat stress and heat degradation when drying delicate biomolecules. It uses a combination of laminar flow thermodynamics and mass transfer. So how exactly does it work?
Discover the 5 benefits for biologics
It’s high-yield and low-waste - delivering a process yield of around 80%. Ambient drying is also being developed to be integrated into pharmaceutical manufacturing as an aseptic, one-step industrial process.
How can you capture the benefits?
We target 3 high-value vaccines
Ziccum focuse on three key vaccine platforms – mRNA / LNP, Viral Vectors using adenovirus and Subunit Adjuvanted vaccines. Mass Trasnfer drying is of great relevance to high-value therapies from personalized vaccines to cancer vaccines.
Next-generation administration routes
With unique particle engineering capabilities, LaminarPace enables the formulation of a wide range of next-generation administration routes – from inhaled to mucosal to transdermal treatments and therapies.